Home › Therapeutic areas › Respiratory › COPD

COPD (5 companies)

Companies with an active program in COPD.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 1 Phase 2 — 9
CNTB Connect Biopharma Respiratory 2 Phase 2 $37.3M 4
LQDA Liquidia CardiovascularImmunology+1 Rare 1 Approved $5.11B 9
UPB Upstream Bio Respiratory 1 Phase 2 $115M 3
ZYME Zymeworks OncologyRespiratory 2 Approved $1.78B 12